Caglayan, V., Onen, E., Avci, S., Sambel, M., Kilic, M., Oner, S., Aydos, M.M. and Yıldız, H.E. 2019. Lymphocyte-to-monocyte ratio is a valuable marker to predict prostate cancer in patients with prostate specific antigen between 4 and 10 ng/dl. Archivio Italiano di Urologia e Andrologia. 90, 4 (Jan. 2019), 270–275. DOI:https://doi.org/10.4081/aiua.2018.4.270.